The UK Life insurance industry is ‘under intense political scrutiny and we expect further reforms', Standard & Poor's has warned in a new report.
Cancer accounts for almost a third (29%) of all long-term sickness claims paid in the past year, latest claims data from Unum reveals.
The NHS has proposed removing some drugs from the list of those funded by the Cancer Drugs Fund (CDF).
The winners of Britain's Healthiest Company have been announced, including Old Mutual which won as the healthiest small company.
CEGA will continue to provide its global assistance services to clients of Western Provident Association, (WPA) for a further two years.
Unum's acquisition of National Dental Plan (NDP) has been given regulatory approval.
Jelf has released two whitepapers on benefits technology to help employers have a more consolidated approach to employee benefits.
Omnilife has been granted a Standard & Poor's rating for the first time since its launch into the UK insurance market.
APRIL UK has upgraded the cancer benefits on their inSpire Private Medical Insurance Plan without any change to premiums.
Royal London has announced a new fundraising goal of £68,000 for the charity Bloodwise, formerly Leukaemia & Lymphoma Research.